Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Previous studies on synchronous colorectal carcinoma (SCRC) have reported inconsistent results about its clinicopathologic and molecular features and prognostic significance. Methods: Forty-six patients with multiple advanced tumors (T2 or higher category) who did not receive neoadjuvant chemotherapy and/or radiotherapy and who are not associated with familial adenomatous polyposis were selected and 99 tumors from them were subjected to clinicopathologic and molecular analysis. Ninety-two cases of solitary colorectal carcinoma (CRC) were selected as a control considering the distributions of types of surgeries performed on patients with SCRC and T categories of individual tumors from SCRC. Results: SCRC with multiple advanced tumors was significantly associated with more frequent nodal metastasis (p = .003) and distant metastasis (p = .001) than solitary CRC. KRAS mutation, microsatellite instability, and CpG island methylator phenotype statuses were not different between SCRC and solitary CRC groups. In univariate survival analysis, overall and recurrence-free survival were significantly lower in patients with SCRC than in patients with solitary CRC, even after adjusting for the extensiveness of surgical procedure, adjuvant chemotherapy, or staging. Multivariate Cox regression analysis revealed that tumor multiplicity was an independent prognostic factor for overall survival (hazard ratio, 4.618; 95% confidence interval, 2.126 to 10.030; p < .001), but not for recurrence-free survival (p = .151). Conclusions: Findings suggested that multiplicity of advanced T category–tumors might be associated with an increased risk of nodal metastasis and a risk factor for poor survival, which raises a concern about the guideline of American Joint Committee on Cancer’s tumor-node-metastasis staging that T staging of an index tumor determines T staging of SCRC.
Abstract
Background: Previous studies on synchronous colorectal carcinoma (SCRC) have reported inconsistent results about its clinicopathologic and molecular features and prognostic significance. Methods: Forty-six patients with multiple advanced tumors (T2 or higher category) who did not receive neoadjuvant chemotherapy and/or radiotherapy and who are not associated with familial adenomatous polyposis were selected and 99 tumors from them were subjected to clinicopathologic and molecular analysis. Ninety-two cases of solitary colorectal carcinoma (CRC) were selected as a control considering the distributions of types of surgeries performed on patients with SCRC and T categories of individual tumors from SCRC. Results: SCRC with multiple advanced tumors was significantly associated with more frequent nodal metastasis (p = .003) and distant metastasis (p = .001) than solitary CRC. KRAS mutation, microsatellite instability, and CpG island methylator phenotype statuses were not different between SCRC and solitary CRC groups. In univariate survival analysis, overall and recurrence-free survival were significantly lower in patients with SCRC than in patients with solitary CRC, even after adjusting for the extensiveness of surgical procedure, adjuvant chemotherapy, or staging. Multivariate Cox regression analysis revealed that tumor multiplicity was an independent prognostic factor for overall survival (hazard ratio, 4.618; 95% confidence interval, 2.126 to 10.030; p < .001), but not for recurrence-free survival (p = .151). Conclusions: Findings suggested that multiplicity of advanced T category–tumors might be associated with an increased risk of nodal metastasis and a risk factor for poor survival, which raises a concern about the guideline of American Joint Committee on Cancer’s tumor-node-metastasis staging that T staging of an index tumor determines T staging of SCRC.
참고문헌 (36)
- Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
- Ghiringhelli F, "Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study", Dig Liver Dis, 46, pp.854~858 (2014)
- Kaibara N, "Synchronous and metachronous malignancies of the colon and rectum in Japan with special reference to a coexisting early cancer", Cancer, 54, pp.1870~1874 (1984)
- Lam AK, "Synchronous colorectal cancer: clinical, pathological and molecular implications", World J Gastroenterol, 20, pp.6815~6820 (2014)
- Oya M, "Synchronous colorectal carcinoma: clinico-pathological features and prognosis", Jpn J Clin Oncol, 33, pp.38~43 (2003)
- Yang J, "Synchronous colorectal cancers: a review of clinical features, diagnosis, treatment, and prognosis", Dig Surg, 28, pp.379~385 (2011)
- Cunliffe WJ, "Incidence of synchronous and metachronous colorectal carcinoma", Br J Surg, 71, pp.941~943 (1984)
- Evers BM, "Multiple adenocarcinomas of the colon and rectum: an analysis of incidences and current trends", Dis Colon Rectum, 31, pp.518~522 (1988)
- Fukatsu H, "Clinical characteristics of synchronous colorectal cancer are different according to tumour location", Dig Liver Dis, 39, pp.40~46 (2007)
- Hu H, "Clinicopathologic features of synchronous colorectal carcinoma: a distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis", Am J Surg Pathol, 37, pp.1660~1670 (2013)
- Kimura T, "Synchronous colorectal carcinomas", Hepatogastroenterology, 41, pp.409~412 (1994)
- Latournerie M, "Epidemiology and prognosis of synchronous colorectal cancers", Br J Surg, 95, pp.1528~1533 (2008)
- Mulder SA, "Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study", Cancer Epidemiol, 35, pp.442~447 (2011)
- Ueno M, "Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer", Int J Clin Oncol, 8, pp.162~167 (2003)
- Wang HZ, "Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma", World J Gastroenterol, 10, pp.2136~2139 (2004)
- Kato T, "Clinical characteristics of synchronous colorectal cancers in Japan", World J Surg Oncol, 14, pp.272~ (2016)
- Chen HS, "Synchronous and “early” metachronous colorectal adenocarcinoma: analysis of prognosis and current trends", Dis Colon Rectum, 43, pp.1093~1099 (2000)
- Finan PJ, "Synchronous and ‘early’ metachronous carcinomas of the colon and rectum", Br J Surg, 74, pp.945~947 (1987)
- 김용진, "다발성 원발성 대장 직장암의 임상 병리학적 특성", Annals of Coloproctolgy, 18(5), pp.343~348 (2002), 대한대장항문학회
- 강중구, "다발성 대장직장암의 임상적 특성", Annals of Coloproctolgy, 22(6), pp.418~423 (2006), 대한대장항문학회
- Welch JP, "Multiple colorectal tumors: an appraisal of natural history and therapeutic options", Am J Surg, 142, pp.274~280 (1981)
- Lam AK, "Clinicopathological significance of synchronous carcinoma in colorectal cancer", Am J Surg, 202, pp.39~44 (2011)
- Pedroni M, "Microsatellite instability in multiple colorectal tumors", Int J Cancer, 81, pp.1~5 (1999)
- Norrie MW, "The role of hMLH1 methylation in the development of synchronous sporadic colorectal carcinomas", Dis Colon Rectum, 45, pp.674~680 (2002)
- Dykes SL, "Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer", Cancer, 98, pp.48~54 (2003)
- Nosho K, "A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers", Gastroenterology, 137, pp.1609-20.e1~1609-20.e3 (2009)
- Gonzalo V, "Multiple sporadic colorectal cancers display a unique methylation phenotype", PLoS One, 9, pp.e91033~ (2014)
- Brueckl WM, "Mismatch repair deficiency in sporadic synchronous colorectal cancer", Anticancer Res, 20, pp.4727~4732 (2000)
- Kamiyama H, "DNA demethylation in normal colon tissue predicts predisposition to multiple cancers", Oncogene, 31, pp.5029~5037 (2012)
- Eguchi K, "Discordance of p53 mutations of synchronous colorectal carcinomas", Mod Pathol, 13, pp.131~139 (2000)
- Giannini R, "KRAS and BRAF genotyping of synchronous colorectal carcinomas", Oncol Lett, 7, pp.1532~1536 (2014)
- Ronnekleiv-Kelly SM, "Staging of intrahepatic cholangiocarcinoma", Hepatobiliary Surg Nutr, 6, pp.35~43 (2017)
- Enker WE, "Multiple carcinomas of the large bowel: a natural experiment in etiology and pathogenesis", Ann Surg, 187, pp.8~11 (1978)
- Bae JM, "Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location", Br J Cancer, 109, pp.1004~1012 (2013)
- 오현정, "Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer", Journal of Pathology and Translational Medicine, 51(3), pp.306~313 (2017), 대한병리학회[DOI]
- Bae JM, "Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway", Arch Pathol Lab Med, 140, pp.406~412 (2016)